239 related articles for article (PubMed ID: 36425299)
21. Prognostic significance of CD24 expression in gastric carcinoma.
Darwish NS; Kim MA; Chang MS; Lee HS; Lee BL; Kim YI; Kim WH
Cancer Res Treat; 2004 Oct; 36(5):298-302. PubMed ID: 20368819
[TBL] [Abstract][Full Text] [Related]
22. CD24 plays an important role in the carcinogenesis process of the pancreas.
Sagiv E; Kazanov D; Arber N
Biomed Pharmacother; 2006 Jul; 60(6):280-4. PubMed ID: 16824727
[TBL] [Abstract][Full Text] [Related]
23. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
24. CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma.
Higashi M; Momose S; Takayanagi N; Tanaka Y; Anan T; Yamashita T; Kikuchi J; Tokuhira M; Kizaki M; Tamaru JI
J Pathol Clin Res; 2022 Jul; 8(4):340-354. PubMed ID: 35289116
[TBL] [Abstract][Full Text] [Related]
25. The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.
Smith SC; Oxford G; Wu Z; Nitz MD; Conaway M; Frierson HF; Hampton G; Theodorescu D
Cancer Res; 2006 Feb; 66(4):1917-22. PubMed ID: 16488989
[TBL] [Abstract][Full Text] [Related]
26. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy.
Ni YH; Zhao X; Wang W
Curr Gene Ther; 2020; 20(2):109-126. PubMed ID: 32576128
[TBL] [Abstract][Full Text] [Related]
27. Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules.
Fischer GF; Majdic O; Gadd S; Knapp W
J Immunol; 1990 Jan; 144(2):638-41. PubMed ID: 2153173
[TBL] [Abstract][Full Text] [Related]
28. The CD24 antigen discriminates between pre-B and B cells in human bone marrow.
Duperray C; Boiron JM; Boucheix C; Cantaloube JF; Lavabre-Bertrand T; Attal M; Brochier J; Maraninchi D; Bataille R; Klein B
J Immunol; 1990 Dec; 145(11):3678-83. PubMed ID: 1700990
[TBL] [Abstract][Full Text] [Related]
29. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
Schabath H; Runz S; Joumaa S; Altevogt P
J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
[TBL] [Abstract][Full Text] [Related]
30. CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells.
Davidson B
Hum Pathol; 2016 Dec; 58():123-127. PubMed ID: 27589896
[TBL] [Abstract][Full Text] [Related]
31. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.
Uckun FM; Song CW
Blood; 1993 Mar; 81(5):1323-32. PubMed ID: 8443393
[TBL] [Abstract][Full Text] [Related]
32. Gene expression of CD24 core peptide molecule in developing brain and developing non-neural tissues.
Shirasawa T; Akashi T; Sakamoto K; Takahashi H; Maruyama N; Hirokawa K
Dev Dyn; 1993 Sep; 198(1):1-13. PubMed ID: 8292828
[TBL] [Abstract][Full Text] [Related]
33. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
[TBL] [Abstract][Full Text] [Related]
34. The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo.
Shapira S; Kazanov D; Weisblatt S; Starr A; Arber N; Kraus S
J Biol Chem; 2011 Nov; 286(47):40548-55. PubMed ID: 21976680
[TBL] [Abstract][Full Text] [Related]
35. CD24 induces changes to the surface receptors of B cell microvesicles with variable effects on their RNA and protein cargo.
Ayre DC; Chute IC; Joy AP; Barnett DA; Hogan AM; Grüll MP; Peña-Castillo L; Lang AS; Lewis SM; Christian SL
Sci Rep; 2017 Aug; 7(1):8642. PubMed ID: 28819186
[TBL] [Abstract][Full Text] [Related]
36. CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis.
Burgos-Ojeda D; Wu R; McLean K; Chen YC; Talpaz M; Yoon E; Cho KR; Buckanovich RJ
Mol Cancer Ther; 2015 Jul; 14(7):1717-27. PubMed ID: 25969154
[TBL] [Abstract][Full Text] [Related]
37. STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells.
Lin L; Jou D; Wang Y; Ma H; Liu T; Fuchs J; Li PK; Lü J; Li C; Lin J
Int J Oncol; 2016 Dec; 49(6):2265-2274. PubMed ID: 27748818
[TBL] [Abstract][Full Text] [Related]
38. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.
Barkal AA; Brewer RE; Markovic M; Kowarsky M; Barkal SA; Zaro BW; Krishnan V; Hatakeyama J; Dorigo O; Barkal LJ; Weissman IL
Nature; 2019 Aug; 572(7769):392-396. PubMed ID: 31367043
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades.
Jacob J; Bellach J; Grützmann R; Alldinger I; Pilarsky C; Dietel M; Kristiansen G
Pancreatology; 2004; 4(5):454-60. PubMed ID: 15256807
[TBL] [Abstract][Full Text] [Related]
40. Novel insights into the function of CD24: A driving force in cancer.
Altevogt P; Sammar M; Hüser L; Kristiansen G
Int J Cancer; 2021 Feb; 148(3):546-559. PubMed ID: 32790899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]